Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

3.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.2K
CRISPR01:59

CRISPR

60.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.3K
CRISPR01:59

CRISPR

19.0K
19.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

20.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
20.4K
Homologous Recombination02:31

Homologous Recombination

65.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.9K
RNA Editing02:23

RNA Editing

10.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Prime Editing Efficiency in Human Immortalized MSC-TERT Cells with Osteogenic Potential for Modeling <i>FGFR2</i>-Linked Craniosynostosis.

The CRISPR journal·2026
Same author

A phage-encoded anti-CRISPR protein co-opts host enolase to prevent type III CRISPR immunity.

Nature microbiology·2025
Same author

An updated evolutionary classification of CRISPR-Cas systems including rare variants.

Nature microbiology·2025
Same author

Structural basis for retron co-option of anti-phage ATPase-nuclease.

Nature structural & molecular biology·2025
Same author

The twist-and-squeeze activation of CARF-fused adenosine deaminase by cyclic oligoadenylates.

The EMBO journal·2025
Same author

The Escherichia coli replication initiator DnaA is titrated on the chromosome.

Nature communications·2025
Same journal

Keep the Hubble and James Webb Space Telescopes alive - the science is worth the price tag.

Nature·2026
Same journal

Say hello to hard helium.

Nature·2026
Same journal

How to avoid dementia - what the science really says.

Nature·2026
Same journal

Save Hubble: the race to preserve the space telescope kicks off.

Nature·2026
Same journal

How long can humans live? All evidence points to a maximum of 125 years.

Nature·2026
Same journal

Listen to Gen Z when it comes to AI in education.

Nature·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
11:35

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

13.4K

Molecular basis for methylation-sensitive editing by Cas9.

Mitchell O Roth1, Yuerong Shu1, Yu Zhao1

  • 1Department of Structural Biology, Van Andel Institute, Grand Rapids, MI, USA.

Nature
|April 15, 2026
PubMed
Summary
This summary is machine-generated.

A new methylation-sensitive CRISPR-Cas9 tool, ThermoCas9, precisely edits DNA by avoiding methylated sites. This advance enables targeted genome editing in specific cells, including those with disease-related hypomethylation.

More Related Videos

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.9K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

8.6K

Related Experiment Videos

Last Updated: Apr 17, 2026

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
11:35

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

13.4K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.9K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

8.6K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • CRISPR-Cas9 is a powerful genome editing tool.
  • DNA methylation is prevalent in genomes but underutilized by Cas9.
  • A need exists for genome editing tools sensitive to DNA methylation patterns.

Purpose of the Study:

  • To characterize a novel methylation-sensitive Cas9 (ThermoCas9).
  • To elucidate the structural basis of its methylation sensitivity.
  • To demonstrate its utility in human cell lines and disease contexts.

Main Methods:

  • Biochemical assays to determine DNA binding and cleavage activity.
  • Cryo-electron microscopy to determine high-resolution structures.
  • Genome editing experiments in human cell lines with varying methylation levels.

Main Results:

  • ThermoCas9 efficiently binds and cleaves DNA at specific PAM sequences (5'-NNNNCGA-3' or 5'-NNNNCCA-3').
  • Methylation of cytosine in the PAM sequence significantly inhibits ThermoCas9 activity.
  • Structural analysis revealed the molecular basis for PAM methylation sensitivity.
  • Demonstrated methylation-sensitive genome editing in human cells.
  • Showcased targeted editing of hypomethylated genes in breast cancer cells using enhanced ThermoCas9.

Conclusions:

  • ThermoCas9 offers precise genome editing by exploiting DNA methylation differences.
  • Its sensitivity to DNA methylation provides an additional layer of specificity for genome editing technologies.
  • ThermoCas9 holds potential for targeting cells with disease-related hypomethylation patterns.